Eligibility NCT00331890 Acute Stroke. Cerebral Infarction.

Alter älter als 18 Jahre

Ja

Nein

Patients must be treated within 24 hours of their initial stroke symptoms onset.

Ja

Nein

Patients with a measurable focal neurological deficit lasting for a minimum of 60 minutes.

Ja

Nein

Patients must have a CT scan and/or conventional MRI compatible with the clinical diagnosis of acute ischemic stroke prior to being randomized.

Ja

Nein

Patients must have an acute ischemic stroke referable to the middle cerebral artery territory

Ja

Nein

At inclusion, NIHSS score > 7, with at least 2 of these points from sections 5 & 6 (motor)

Ja

Nein

Immediately (i.e. minutes) pre-stroke, MRS < 2

Ja

Nein

Women of childbearing potential must have a negative pregnancy test prior to enrolment

Ja

Nein

Signed informed consent

Ja

Nein

Patients in coma: patients having a score of >=2 in the items regarding the level of consciousness in the NIHSS (1a)

Ja

Nein

CT or conventional MRI evidence of brain tumor, cerebral edema with a clinically significant mass midline shift with compression of the ventricles, brainstem or cerebellar infarction, subarachnoid and/or intracerebral and/or intraventricular hemorrhage

Ja

Nein

History of ventricular dysrhythmias, acute myocardial infarction within 72 hours prior to enrolment, unstable angina, decompensated congestive heart failure or any other acute, severe, uncontrollable or sustained cardiovascular condition that, in the Investigator's opinion, may interfere with effective participation in the study

Ja

Nein

Previous disorders that may confound the interpretation of the neurological scales

Ja

Nein

Drug addiction-related disorders

Ja

Nein

Pre existing dementia, when dementia implies a disability, measured as an score of >=2 in the previous MRS

Ja

Nein

Pre existing medical condition that, in the Investigator's opinion, may interfere with the patient's suitability and participation in the study

Ja

Nein

Patients participating in another clinical trial or receiving a non-approved drug (clinical investigational drug) <30 days prior to screening

Ja

Nein

Patients under current treatment with citicoline

Ja

Nein